This federal contract award is a delivery order with a firm fixed price of $7,869.62 issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of 4566640318 - CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 6, 2024.
The contract was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely a task order or delivery order issued against that IDC.
The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a history of federal contract awards, particularly with the DLA, to supply a wide range of pharmaceutical and medical products to support U.S. military and federal healthcare needs.
Generated 3/7/25, 10:07 AM